Management of severe acne
Authors:
- 19 June 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 172, 27-36
Abstract
Acne is the most common skin disease, affecting up to 95% of adolescents. Severe episodes of acne can cause considerable physical and psychological scarring, and overexpression of transforming growth factor-β can lead to formation of hypertrophic scars and keloids. The severity of acne in adolescence is associated with a positive history of severe acne in first-degree relatives, especially the mother. In most cases acne is a chronic disease, and it is often a component of systemic diseases or syndromes. All forms of severe acne require systemic treatment. The available options include oral antibiotics, hormonal antiandrogens for female patients and oral isotretinoin, as well as other combination treatments. Oral isotretinoin is the only drug available that affects all four pathogenic factors of acne. However, due to possible serious side-effects, a European directive states that oral isotretinoin should be used only as a second-line therapy in cases of severe, nodular and conglobate acne. The pharmaceutical quality of generic isotretinoin products and the obtainability of isotretinoin through e-pharmacies without prescription raise new therapeutic problems. New anti-inflammatory compounds, such as the 5-lipoxygenase inhibitor zileuton, may replace systemic antibiotics in the future, especially under the scope of antibiotic resistance prevention. This review looks into the various options and latest approaches, and factors to consider, when combating severe acne.Keywords
Funding Information
- Pierre Fabre Dermo-Cosmétique, France
This publication has 80 references indexed in Scilit:
- Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgarisNature Communications, 2014
- Acne as a chronic systemic diseaseClinics in Dermatology, 2014
- Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based studyBritish Journal of Dermatology, 2014
- Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acneNature Communications, 2014
- A genome-wide association study of severe teenage acne in European AmericansHuman Genetics, 2013
- Epidemiology of acne vulgarisBritish Journal of Dermatology, 2012
- The evidence for the role of transforming growth factor‐beta in the formation of abnormal scarringInternational Wound Journal, 2011
- Prevalence, Severity, and Severity Risk Factors of Acne in High School Pupils: A Community-Based StudyJournal of Investigative Dermatology, 2009
- Predictors of severity of acne vulgaris in young adolescent girls: Results of a five-year longitudinal studyThe Journal of Pediatrics, 1997
- Acne Vulgaris in Early Adolescent BoysArchives of Dermatology, 1991